N-3 LC-PUFA-enriched dairy products are able to reduce cardiovascular risk factors: A double-blind, cross-over study

Clinical Nutrition

Volumn 29, Issue 5, 2010, Pages 592-599

  Dawczynski, Christine ^a   Martin, Lena ^a   Wagner, Andreas ^a   Jahreis, Gerhard ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Dairy products; DNA damage; N 3 LC PUFA; Serum lipids

Indexed keywords

7,8 DIHYDRO 8 OXO 2' DEOXYGUANOSINE; AMINO ACID; CHOLESTEROL; DEOXYGUANOSINE DERIVATIVE; DNA; FATTY ACID; HIGH DENSITY LIPOPROTEIN; ICOSAPENTAENOIC ACID; LONG CHAIN FATTY ACID; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID; PLACEBO; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; AUTOANALYZER; BLOOD SAMPLING; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DAIRY PRODUCT; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE SEVERITY; DNA DAMAGE; DOUBLE BLIND PROCEDURE; FEMALE; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; URINALYSIS;

AGED; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-OVER STUDIES; DAIRY PRODUCTS; DOUBLE-BLIND METHOD; FATTY ACIDS, OMEGA-3; FEMALE; FOOD, FORTIFIED; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; TRIGLYCERIDES;

EID: 77957334617     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2010.02.008     Document Type: Article

References (46)

1. Ruxton C.H., Reed S.C., Simpson M.J., Millington K.J. The health benefits of omega-3 polyunsaturated fatty acids: a review of the evidence. J Hum Nutr Diet 2004, 17:449-459.
2. Marchioli R., Barzi F., Bomba E., Chieffo C., Di Gregorio D., Di Mascio R., et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction - time course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Myocardio (GISSI)-Prevenzione. Circulation 2002, 105:1897-1903.
3. Geelen A., Brouwer A., Schouten E.G., Maan A.C., Katan M.B., Zock P.L. Effects of n-3 fatty acids from fish on premature ventricular complexes and heart rate in humans. Am J Clin Nutr 2005, 81:416-420.
4. Thies F., Garry J.M., Yaqoob P., Rerkasem K., Williams J., Shearman C.P., et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 2003, 361:477-485.
5. Hjerkinn E.M., Seljeflot I., Ellingsen I., Bergstad P., Hjermann I., Sandvik L., et al. Influence of long-term intervention with dietary counseling, long chain n-3 fatty acid supplements, or both on circulation markers of endothelial activation in men with long-standing hyperlipidemia. Am J Clin Nutr 2005, 81:583-589.
6. Harris W.S. Omega-3 fatty acids and cardiovascular disease: a case for omega-3 index as a new risk factor. Pharmacol Res 2007, 55:217-223.
7. Harris W.S., Kris-Etherton P.M., Harris K.A. Intakes of long-chain omega-3 fatty acid associated with reduced risk for death from coronary heart disease in healthy adults. Curr Atheroscler Rep 2008, 10:503-509.
8. DGE Ernährungsbericht 2004 2004, DGE Medien Service, Bonn. Deutsche Gesellschaft für Ernährung e.V (Ed.).
9. Gebauer S.K., Psota T.L., Harris W.S., Kris-Etherton P.M. N-3 fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. Am J Clin Nutr 2006, 83:1526-1535.
10. Dawczynski C., Schubert R., Hein G., Müller A., Eidner T., Vogelsang H., et al. Long-term moderate intervention with n-3 LC-PUFA-supplemented dairy products: effects on pathophysiological biomarkers in rheumatoid arthritis. Br J Nutr 2009, 101:1517-1526.
11. Kraft J., Collomb M., Möckel P., Sieber R., Jahreis G. Differences in CLA isomer distribution of cow's milk lipids. Lipids 2003, 38:657-664.
12. Ebringer L., Ferencík M., Krajcovic J. Beneficial health effects of milk and fermented dairy products - review. Folia Microbiol (Praha) 2008, 53:378-394.
13. Elwood P.C., Pickering J.E., Hughes J., Fehily A.M., Ness A.R. Milk drinking, ischaemic heart disease and ischaemic stroke II. Evidence from cohort studies. Eur J Clin Nutr 2004, 58:718-724.
14. Elwood P.C., Strain J.J., Robson P.J., Fehily A.M., Hughes J., Pickering J., et al. Milk consumption, stroke, and heart attack risk: evidence from the Caerphilly cohort of older men. J Epidemiol Community Health 2005, 59:502-505.
15. Wang L., Manson J.E., Buring J.E., Lee I.M., Sesso H.D. Dietary intake of dairy products, calcium, and vitamin D and the risk of hypertension in middle-aged and older women. Hypertension 2008, 51:1073-1079.
16. Burton G.W., Ingold K.U., Thompson K.E. An improved procedure for the isolation of ghost membranes from human red blood cells. Lipids 1981, 16:946.
17. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959, 37:911-917.
18. Harris W.S., von Schacky C. The omega-3 index: a new risk factor for death from coronary heart disease?. Prev Med 2004, 39:212-220.
19. Kuhnt K., Wagner A., Kraft J., Basu S., Jahreis G. Dietary supplementation with 11 trans- and 12 trans-18:1 and oxidative stress in humans. Am J Clin Nutr 2006, 84:981-988.
20. D-A-C-H Recommendations for the nutrient supply 2000, Umschau/Braus GmbH, Frankfurt/Main, 1. Auflage. 1st ed.
21. Sun Q., Ma J., Campos H., Hankinson S.E., Hu F.B. Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US woman. Am J Clin Nutr 2007, 86:74-81.
22. Adam O., Beringer C., Kless T., Lemmen C., Adam A., Wiseman M., et al. Anti-inflammatory effects of low arachidonic acid diet and fish oil in patients with rheumatoid arthritis. Rheumatol Int 2003, 23:27-36.
23. Cao J., Schichtenberg K.A., Hanson N.Q., Tsai M.Y. Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids. Clin Chem 2006, 52:2265-2272.
24. Jabbar R., Saldeen T. A new predictor of risk for sudden cardiac death. Ups J Med Sci 2006, 111:169-178.
25. Siscovick D.S., Raghunathan T.E., King I., Weinmann S., Wicklund K.G., Albright J., et al. Dietary intake and cell membrane levels of long chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 1995, 274:1363-1367.
26. Albert C.M., Campos H., Stampfer M.J., Ridker P.M., Manson J.E., Willett W.C., et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002, 346:1113-1118.
27. Milte C.M., Coates A.M., Buckley J.D., Hill A.M., Howe P.R. Dose-dependent effects of docosahexaenoic acid-rich fish oil on erythrocyte docosahexaenoic acid and blood lipid levels. Br J Nutr 2008, 99:1083-1088.
28. De Roos B., Geelen A., Ross K., Rucklidge G., Reid M., Duncan G., et al. Identification of potential serum biomarkers of inflammation and lipid modulation that are altered by fish oil supplementation in healthy volunteers. Proteomics 2008, 8:1965-1974.
29. Jacobson T.A. Role of n-3 fatty acids in the treatment of hypertriglyceridemia and cardiovascular disease. Am J Clin Nutr 2008, 87:1981-1990.
30. Hartweg J., Farmer A.J., Perera R., Holman R.R., Neil H.A. Meta-analysis of the effects of n-3 polyunsaturated fatty acids on lipoproteins and other emerging lipid cardiovascular risk markers in patients with type 2 diabetes. Diabetologia 2007, 50:1593-1602.
31. Rubins H.B., Robins S.J., Collins D., Fye C.L., Anderson J.W., Elam M.B., et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 1999, 341:410-418.
32. Mensink R.P., Zock P.L., Kester A.D.M., Katan M.B. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 2003, 77:1146-1155.
33. Balk E.M., Lichtenstein A.H., Chung M., Kupelnick B., Chew P., Lau J. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis 2006, 189:19-30.
34. Kießling G., Schneider J., Jahreis G. Long-term consumption of fermented dairy products over 6 months increases HDL cholesterol. Eur J Clin Nutr 2002, 56:843-849.
35. Demaison L., Moreau D. Dietary n-3 polyunsaturated fatty acids and coronary heart disease-related mortality: a possible mechanism of action. Cell Mol Life Sci 2002, 59:463-477.
36. Fontaine-Bisson B., Wolever T.M., Chiasson J.L., Rabasa-Lhoret R., Mahuex P., Josse R.G., et al. Genetic polymorphisms of tumor necrosis factor-a modify the association between dietary polyunsaturated fatty acids and fasting HDL cholesterol and apo A-I concentrations. Am J Clin Nutr 2007, 86:768-774.
37. Madden J., Carrero J.J., Brunner A., Dastur N., Shearman C.P., Calder P.C., et al. Polymorphisms in the CD36 gene modulate the ability of fish oil supplements to lower fasting plasma triacylglycerol and raise HDL cholesterol concentrations in healthy middle-aged men. Prostaglandins Leukot Essent Fatty Acids 2008, 78:327-335.
38. Madsen T., Christensen J.H., Schmidt E.B. C-reactive protein and n-3 fatty acids in patients with a previous myocardial infarction: a placebo-controlled randomized study. Eur J Nutr 2007, 46:428-430.
39. Associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: individual participant meta-analysis of 154,211 adults in 31 prospective studies: the fibrinogen studies collaboration. Am J Epidemiol 2007, 166:867-879. The Fibrinogen Studies Collaboration.
40. Conquer J.A., Cheryk L.A., Chan E., Gentry P.A., Holub B.J. Effect of supplementation with dietary seal oil on selected cardiovascular risk factors and hemostatic variables in healthy male subjects. Thromb Res 1999, 96:239-250.
41. Sanders T.A., Lewis F., Slaughter S., Griffin B.A., Griffin M., Davies I., et al. Effect of varying the ratio of n-6 to n-3 fatty acids by increasing the dietary intake of alpha-linolenic acid, eicosapentaenoic acid and docosahexaenoic acid, or both on fibrinogen and clotting factors VII and XII in persons aged 45-70y: the OPTILIP study. Am J Clin Nutr 2006, 84:513-522.
42. Cho S.H., Im J.G., Choi Y.S., Son Y.S., Chung M.H. Lipid peroxidation and 8-hydroxydeoxyguanosine formation in rats fed fish oil with different levels of vitamin E. J Nutr Sci Vitaminol 1995, 41:61-72.
43. Kikugawa K., Yasuhara Y., Ando K., Koyama K., Hiramoto K., Suzuki M. Protective effect of supplementation of fish oil with high n-3 polyunsaturated fatty acids against oxidative stress-induced DNA damage of rat liver in vivo. J Agric Food Chem 2003, 51:6073-6079.
44. Loft S., Thorling E.B., Poulsen H.E. High fat diet induced oxidative DNA damage estimated by 8-oxo-7,8-dihydro-2-deoxyguanosine excretion in rats. Free Radic Res 1998, 29:595-600.
45. De Kok T.M., ten Vaarwerk F., Zwingman I., van Maanen J.M., Kleinjans J.C. Peroxidation of linoleic, arachidonic and oleic acid in relation to the induction of oxidative DNA damage and cytogenetic effects. Carcinogenesis 1994, 15:1399-1404.
46. Calder P.C. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006, 83:1505-1519.